Patent · US Active

Uses of indole-ketones or indolidones as neuro-protective drugs

US9486440B2 · kind B2 · utility

0Cited by

2References

8Claims

0Family size

Assignees

University of Macau · CN
The Hong Kong Polytechnic University · CN

Inventors

Ming Yuen LEE · Cotai Landfill Zone, CN
Yifan Han · Zhengzhou, CN
Chung Lit Choi · Hong Kong, CN
Zaijun Zhang · 流花街道, CN
Wei Cui · London, GB

Key dates

Filing date	Oct 25, 2012
Grant date	Nov 8, 2016
Priority date	—
Expiry date	Oct 25, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/28
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides a method of using indole-ketone or indolidone such as SU4312, SU5416, SU11248 (Sunitinib), or indirubin-3-oxime to treat a neurodegenerative disease or disorder such as Parkinson's disease which is associated with excessive neuronal Nitric Oxide Synthase (nNOS) activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.